APDN NASDAQ
Applied DNA Sciences, Inc.
1W: -9.3%
1M: -20.4%
3M: -25.3%
1Y: -97.6%
3Y: -100.0%
5Y: -100.0%
$5.62
Last traded 2025-11-03 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$2M
-37.7% ▼
5Y CAGR: +2.0%
Gross Profit
$839K
-17.5% ▼
5Y CAGR: -7.1%
Operating Income
-$16M
-14.4% ▼
Net Income
-$69M
-893.7% ▼
EPS (Diluted)
$-134.23
-7275.3% ▼
EBITDA
-$16M
-20.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9M | $18M | $13M | $3M | $2M |
| YoY Growth | +367.4% | +101.3% | -26.4% | -74.3% | -37.7% |
| Cost of Revenue | $4M | $13M | $8M | $2M | $1M |
| Gross Profit | $5M | $5M | $6M | $1M | $839K |
| Gross Margin | 54.6% | 27.8% | 41.4% | 29.6% | 39.3% |
| R&D Expenses | $4M | $4M | $4M | $4M | $6M |
| SG&A Expenses | $13M | $15M | $13M | $11M | $11M |
| Operating Expenses | $17M | $19M | $16M | $15M | $17M |
| Operating Income | -$12M | -$14M | -$11M | -$14M | -$16M |
| Operating Margin | -136.2% | -76.9% | -81.9% | -408.7% | -750.9% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$14M | -$8M | -$10M | -$7M | -$16M |
| Tax Expense | $0 | $0 | $0 | $0 | $684K |
| Net Income | -$16M | -$8M | -$10M | -$7M | -$69M |
| Net Margin | -177.6% | -46.1% | -74.4% | -203.8% | -3251.7% |
| EPS (Diluted) | $-46.35 | $-18.68 | $-15.21 | $-1.82 | $-134.23 |
| EBITDA | -$12M | -$13M | -$10M | -$13M | -$16M |
| Shares Outstanding | 345850 | 448385 | 653771 | 4M | 517671 |